Innate Pharma
IPHA
#8372
Rank
HK$1.30 B
Marketcap
HK$14.93
Share price
7.26%
Change (1 day)
-25.82%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -HK$65.06 Million

According to Innate Pharma 's latest financial reports the company's current earnings are HK$57.37 Million. In 2023 the company made an earning of -HK$65.06 Million, an increase over its 2022 earnings that were of -HK$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-HK$65.06 Million-86.54%
2022-HK$0.49 Billion20.74%
2021-HK$0.41 Billion4951.09%
2020-HK$7.93 Million-111.57%
2019HK$68.51 M183.46%
2018HK$24.17 M-105.4%
2017-HK$0.45 Billion-523.25%
2016HK$0.10 B-285.64%
2015-HK$57 Million-69.31%
2014-HK$0.19 Billion498.29%
2013-HK$31.05 Million-5.62%
2012-HK$32.9 Million-53.32%
2011-HK$70.47 Million-50.1%
2010-HK$0.15 Billion-13.3%
2009-HK$0.17 Billion26.36%
2008-HK$0.13 Billion27.35%
2007-HK$0.11 Billion63.33%
2006-HK$61.98 Million9.81%
2005-HK$56.44 Million